Files

Download

Download Full Text (593 KB)

Document Type

Poster

Description

• Many patients with asthma have poorly controlled disease despite the use of both an inhaled corticosteroid (ICS) and a long acting beta agonist (LABA).

• The review explored several studies that compared the addition of tiotropium to patients with uncontrolled asthma currently using both a ICA and a LABA to determine if further symptom reduction is obtained along with reduction of exacerbations

• It was found that patients with poorly controlled asthma will benefit from the addition of tiotropium to the current medication regimen of an ICS and a LABA. Tiotropium offers providers an additional disease controlling option in cases where treatment is already limited.

Department

Physician Assistant Studies

Degree Name

Master of Physician Assistant Studies (MPAS)

First Advisor

Susan Kuntz

Publication Date

2014

Keywords

Anti-Asthmatic Agents -- therapeutic use; Asthma -- drug therapy; Bronchodilator Agents -- therapeutic use; Cholinergic Antagonists -- therapeutic use; Tiotropium Bromide -- therapeutic use

Disciplines

Respiratory Tract Diseases

The Addition of Tiotropium in Uncontrolled Asthma

Share

COinS